You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

time window beyond 4.5 hours

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in Worldwide (LY2157299 monohydrate, Lomustine, Placebo)

Active, not recruiting
  • Glioblastoma
  • LY2157299 monohydrate
  • +2 more
  • Birmingham, Alabama
  • +26 more
Oct 18, 2022

Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)

Active, not recruiting
Has Results
  • Breast Neoplasms
  • Fayetteville, Arkansas
  • +141 more
Nov 15, 2022

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)

Active, not recruiting
Has Results
  • Biliary Tract Cancer
  • +2 more
  • Tucson, Arizona
  • +91 more
Oct 18, 2022

Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

Active, not recruiting
Has Results
  • Breast Cancer
  • Chandler, Arizona
  • +166 more
Jul 21, 2022

Stroke Trial in Shenyang (Tenecteplase)

Completed
  • Stroke
  • Shenyang, China
    Department of Neurology, General Hospital of Northern Theater Co
Jul 31, 2022

Gastric Adenocarcinoma, Adenocarcinoma of the Gastroesophageal Junction, NSCLC Trial in Worldwide (Ramucirumab, Pembrolizumab)

Completed
  • Gastric Adenocarcinoma
  • +4 more
  • New Haven, Connecticut
  • +21 more
Aug 17, 2022

Mantle Cell Lymphoma Trial in France, Germany (Abemaciclib)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Lille, France
  • +6 more
Apr 6, 2022

Soft Tissue Sarcoma Trial in Worldwide (Olaratumab, Doxorubicin, Placebo)

Active, not recruiting
Has Results
  • Soft Tissue Sarcoma
  • Duarte, California
  • +117 more
Mar 22, 2022

Stroke Trial in Hangzhou (Alteplase)

Recruiting
  • Stroke
  • Hangzhou, China
    Second Affiliated Hospital of Zhejiang University, School of Med
Jul 14, 2021

Hepatocellular Carcinoma Trial in Worldwide (Ramucirumab, Placebo)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Daly City, California
  • +130 more
Jan 5, 2022

Stroke, Cerebrovascular Accident, Cerebral Infarction Trial in Canada (drug, other, behavioral)

Active, not recruiting
  • Stroke
  • +9 more
  • Fluoxetine Hydrochloride
  • +2 more
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2022

Hormone Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer Trial in Worldwide (Abemaciclib, Trastuzumab, Fulvestrant)

Active, not recruiting
Has Results
  • Hormone Receptor Positive Breast Cancer
  • HER-2 Positive Breast Cancer
  • Bakersfield, California
  • +92 more
Feb 4, 2022

Advanced Cancer Trial in Santa Monica, Boston, San Antonio (LY2835219, Fulvestrant)

Active, not recruiting
  • Advanced Cancer
  • Santa Monica, California
  • +2 more
Oct 4, 2021

Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,

Completed
Has Results
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Fayetteville, Arkansas
  • +134 more
Jul 29, 2021

Stroke Trial in Shanghai (Tenecteplase, nonthrombolysis drug)

Recruiting
  • Stroke
  • Shanghai, Shanghai, China
    Huashan Hospital
Jul 4, 2022

Acute Ischemic Stroke Trial (rhTNK-tPA, Antiplatelet Agents)

Not yet recruiting
  • Acute Ischemic Stroke
  • (no location specified)
Mar 1, 2023

Migraine Trial in Japan (Galcanezumab, Placebo)

Completed
Has Results
  • Migraine
  • Chiba, Japan
  • +46 more
Apr 1, 2021

Cognition Disorders Trial in Worldwide (Placebo, Solanezumab)

Active, not recruiting
  • Cognition Disorders
  • Birmingham, Alabama
  • +67 more
Jan 17, 2023

Stroke, Ischemic Trial in Shenyang (Tenecteplase)

Not yet recruiting
  • Stroke, Ischemic
  • Shenyang, China
    Department of Neurology, General Hospital of Northern Theater Co
Aug 23, 2023

Stroke, Acute Ischemic Trial (Intravenous thrombolysis agents, endovascular thrombectomy)

Not yet recruiting
  • Stroke, Acute Ischemic
  • Intravenous thrombolysis agents
  • endovascular thrombectomy
  • (no location specified)
Nov 21, 2022

Stroke, Ischemic Trial in Shenyang (TNK-Tissue Plasminogen Activator)

Recruiting
  • Stroke, Ischemic
  • TNK-Tissue Plasminogen Activator
  • Shenyang, China
    Department of Neurology, General Hospital of Northern Theater Co
Feb 10, 2022

Stroke Trial in Shanghai (Low dose tenecteplase, High dose tenecteplase)

Completed
  • Stroke
  • Low dose tenecteplase
  • High dose tenecteplase
  • Shanghai, Shanghai, China
    Huashan Hospital
Mar 30, 2022

Stroke, Acute Ischemic Trial (Tissue Plasminogen Activator (Alteplase))

Not yet recruiting
  • Stroke, Acute Ischemic
  • Tissue Plasminogen Activator (Alteplase)
  • (no location specified)
Aug 16, 2022

Alzheimer's Disease Trial in Worldwide (LY3202626, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Irvine, California
  • +75 more
Mar 22, 2021

Acute Ischemic Stroke, Basilar Artery Occlusion Trial in Beijing (Best medical management, Endovascular treatment)

Recruiting
  • Acute Ischemic Stroke
  • Basilar Artery Occlusion
  • Best medical management
  • Endovascular treatment
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Oct 20, 2023